Effect of Ketanserin on Phenylephrine-Dependent Changes in Splanchnic Hemodynamics and Systemic Blood Pressure in Healthy Subjects
- 1 March 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 7 (2) , 219-223
- https://doi.org/10.1097/00005344-198503000-00002
Abstract
The effect of ketanserin on basal status and phenylephrine-dependent changes in arterial blood pressure and splanchnic hemodynamics was studied in 7 healthy subjects. The drug was administered as an i.v. bolus of 10 mg followed by infusion of 4 mg/h. After a basal period of saline or ketanserin infusion, phenylephrine was infused at a constant rate in a fixed dose sequence of 1, 2 and 3 .mu.g/kg min. Blood pressure was measured intraarterially. Splanchnic blood flow, mean wedged hepatic blood pressure and splanchnic vascular resistance were assessed using hepatic venous catheter technique using indocyanine green dye. At steady-state plasma concentrations, basal arterial pressure and heart rate were not altered in this small group of normal subjects; mean wedged hepatic venous pressure was lowered by ketanserin. During saline infusion, phenylephrine provoked a dose-dependent rise in arterial and wedged hepatic blood pressure: these effects were attenuated by ketanserin. Phenylephrine induced a significant but not dose-dependent decrease in estimated splanchnic blood flow. Ketanserin did not relevantly influence basal or phenylephrine-dependent splanchnic blood flow. Evidently, the hypotensive action of ketanserin is in part related to an interaction at .alpha.1-adrenoceptors. A dissociation of effects on vascular .alpha.-receptors seems to exist in the splanchnic and systemic circulations.Keywords
This publication has 14 references indexed in Scilit:
- Pharmacokinetics of ketanserin in manEuropean Journal of Clinical Pharmacology, 1983
- Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agentJournal of Pharmacy and Pharmacology, 1982
- Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.BMJ, 1982
- CHARACTERIZATION OF THE ANTIHYPERTENSIVE PROPERTIES OF KETANSERIN (R-41-468) IN RATS1982
- Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptorsLife Sciences, 1981
- Oral glucose tolerance test: Effect of different glucose loads on splanchnic carbohydrate and substrate metabolism in healthy manMetabolism, 1980
- DIFFERENTIAL INHIBITION OF ALPHA-1 AND ALPHA-2 ADRENOCEPTOR-MEDIATED PRESSOR-RESPONSES IN PITHED RATS1980
- Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal manDiabetologia, 1979
- Indocyanine Green Clearance and Estimated Hepatic Blood Flow during Mild to Maximal Exercise in Upright Man *Journal of Clinical Investigation, 1964
- THE ESTIMATION OF HEPATIC BLOOD FLOW IN MANJournal of Clinical Investigation, 1945